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Giving Patients 
A Second Chance 
The Best Physicians in St. Loui 
n the fields of nuclear medicine, radiation oncology, and 
radiology, Mallinckrodt Institute physicians swept the field 
-of "Best Doctors in St. Louis," as reported in the August 
2002 issue of St. Louis Magazine. The list of 441 doctors in 
37 specialties was compiled by Best Doctors, Inc., a research 
and information company that maintains The Best Doctors in 
America database of approximately 30,000 doctors in more 
than 40 medical specialties. Best Doctors polls thousands of 
physicians worldwide, asking for nominations to the list based 
on patient care rather than academic excellence or research. 
Nuclear Medicine 
Farrokh Dehdashti, MD 
Keith Fischer, MD 
Robert Gropler, MD 
Tom Miller, MD, PhD 
Mark Mintun, MD 
Henry Royal, MD 
Barry Siegel, MD 
Radiation Oncology 
Perry Grigsby, MD 
JeffMichalski, MD 
Robert Myerson, MD, PhD 
Joseph Simpson, MD, PhD 
Marie Taylor, MD 
Todd Wasserman, MD 
Radiology 
Claire Anderson, MD 
DeWitte Cross, MD 
Michael Darcy, MD 
Jay Heiken, MD 
David Hovsepian, MD 
William McAlister, MD 
William Middleton, MD 
Barbara Monsees, MD 
Christopher Moran, MD 
Daniel Picus, MD 
David Rubin, MD 
Stuart Sagel, MD 
Marilyn Siegel, MD 
William Totty, MD 
Thomas Vesely, MD 
Franz Wippold, MD 
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THE WASSERMAN SYMPOSIUM 
The "Current Topics in Cancer Treatment" 
symposium honored Dr. Todd Wasserman for his 
outstanding clinical, academic, and research 
contributions to the field of radiation oncology. 
GIVING PATIENTS A SECOND CHANCE 
Two nonsurgical vascular procedures— 
chemoembolization and radiofrequency 
ablation—combined with the expertise of 
Mallinckrodt Institute's interventional 
radiologists provide a comprehensive approach 
to liver cancer therapy for critically ill patients. 
COMMUNITY-HOSPITAL RADIOLOGY SERVICES 
The partnership of Mallinckrodt Institute and 
Barnes-Jewish West County Hospital offers 
excellent patient care, leading-edge technology, 
and the convenience of a community hospital. 
THE CLINICAL PET CENTER 
With more than a century of collective experience 
in nuclear medicine and positron emission 
tomography, the physicians of the Clinical PET 
Center now have the added advantage of the area's 
only PET/CT scanner to aid in the detection and 
localization of disease. 
A SON'S TRIBUTE 
The pink granite monolith that rests in the atrium 
of the Eric P. Newman Education Center was 
lovingly created by artist Ian Gilula as a lasting 
tribute to his father, Dr. Louis Gilula. 
ON THE COVER Daniel Brown, MD, performs a targeted treatment called radiofrequency 




of the Year 
This year the senior 
diagnostic radiology resi- 
dents elected William 
McAlister, MD, chief of 
pediatric radiology and radi- 
ologist-in-chief at St. Louis 
Childrens Hospital (SLCH), 
as the Mallinckrodt Institute 
faculty member who made 
the most outstanding 
contributions to resident 
education through course 
study, conferences, and 
clinical activities. The pre- 
sentation was made in June 
at the annual farewell dinner 
for residents and fellows, 
which is sponsored by 
Eastman Kodak Company. 
McAlister was named 
chief of pediatric radiology 
in 1965 and professor of 
radiology and of pediatrics 
in 1968. He also serves as 
consulting radiologist for 
Shriners Hospitals for 
Children, St. Louis. 
In addition to an active 
clinical practice, he is 
involved in ongoing research 
of metabolic bone disease 
and skeletal dysplasia with 
Michael Whyte, MD, at 
Shriners Hospital. 
McAlister's seminal research 
on the adverse effects of 
tannic acid on the liver 
prompted the FDA to ban 
the use of tannic acid in bar- 
ium enemas. His NIH-funded 
research focused on the 
microvascularity of trans- 
planted tumors in mice, the 
histologic effects of contrast 
media and ways to modify 
those effects, and alterations 
of the microvascularity in 
experimental renal vein 
obstruction. 
He has served on the 
SLCH Clinical Management 
Committee since 1993 and 
the American College of 
Radiology's (ACR's) 
Committees on Standards 
and Appropriateness since 
1994. McAlister is a fellow of 
the ACR and a diplomate of 
the. American Board of 
Radiology. He is past 
president of the Society for 
Pediatric Radiology (SPR), 
past chairman of the SPR 
Board of Directors, and the 
1998 recipient of the SPR 




In recognition of his 
outstanding work in basic 
radiological sciences, Shao- 
Pow Lin received the Hugh 
M. Wilson Award for Merito- 
rious Work in Radiology. The 
award is presented in honor 
of Doctor Hugh Wilson, 
Mallinckrodt Institute's sec- 
ond director and an advo- 
cate of the advancement of 
education. 
Under the mentorship of 
Jeffrey Neil, MD, PhD, asso- 
ciate professor of neurology, 
of pediatrics, and of radiol- 
ogy, Lin, who received a 
medical degree and a doc- 
toral degree in May, worked 
on several research projects 
in MIR's neuroimaging labo- 
ratory. According to Neil, 
Lin's strong background in 
electrical engineering 
"enabled him to quickly 
learn the nuances of RF coil 
design for magnetic reso- 
nance experiments." Lin 
designed and constructed 
two devices that are now 
being used in the neuroimag- 
ing lab: a transmit/receive 
coil (which Neil says is 
equivalent to those coils 
available commercially) an>! 
a power supply that inter- 
faces with the MR spectrom- 
eter console. 
After completing an 
internship at a St. Louis ho 
pital, Lin will return to 
Mallinckrodt Institute to jo n 
the Research Residency 
Program. 





Laura Ruhrwien, direc- 
tor of information systems 
for Mallinckrodt Institute, 
was inducted into the 
WHO'S WHO Historical 
Society. She will be listed in 
the 2002-2003 edition of 
International WHO'S WHO 
of Information Technology, 
one of a series of highly 
selective and prestigious 
international reference 
books published by the 
North Carolina-based Gibral- 
ter Publishing, Inc. 
Ruhrwien joined the 
staff of MIR in 1997. She pre- 
viously worked in the corpo- 
rate sector as a senior 
manager at Ernst & Young, a 
global financial services 
corporation. 
The History Society, 
which has been document- 
ing multi-indexed unabbre- 
viated biographies of 
successful individuals 
since 1928, provides an 
international forum for 
networking and reference. 
More than 90,000 members 
in 150 countries comprise 
this professional organiza- 
tion. 
Jost appointed 
to ARR, joins 
IS3R 
Gilbert Jost, MD, profes- 
sor of radiology and director 
of Mallinckrodt Institute, 
was appointed to the Execu- 
tive Committee of the Acad- 
emy of Radiology Research 
Board of Directors. In 2000, 
the Academy was instrumen- 
tal in creating a milestone 
for radiology and the imag- 
ing sciences: the National 
Institute of Biomedical Imag- 
ing and Bioengineering 
(NIBIB), the newest of the 
National Institutes of Health 
research institutes and cen- 
ters. The NIBIB will create 
opportunities for research 
that accelerates the develop- 
ment of new imaging tech- 
niques and technologies 
with clinical and research 
applications. 
Jost was invited to join 
the prestigious International 
Society for Strategic Studies 
in Radiology (IS'R). The 
22-member society "serves 
as a marketplace for the 
exchange of ideas and expe- 
rience and has brought 
together the most renowned 
experts [in radiology prac- 
tice and research] in the 
world." The biannual IS'R 
meetings focus on chal- 
lenges to radiologists world- 
wide, current trends in 
radiology, future develop- 
ments in radiological sci- 
ences, and collaboration 





The clinical faculty of 
the Department of Radiation 
Oncology appointed Robert 
Malyapa, MD, PhD, as the 
2002-2003 radiation oncology 
chief resident and Angel 
Blanco, MD, as assistant 
chief resident. Malyapa 
received an undergraduate 
degree from Loyola Univer- 
sity, India, and a medical 
degree from the Jawaharlal 
Institute for Postgraduate 
Medical Research. Blanco 
received an undergraduate 
degree from Emory Univer- 
sity and a medical degree 
from Baylor College of 
Medicine. 
"* 
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At the residents and fellows farewell 
dinner in June, Gilbert Jost, MD, 
director of the Institute, (right) 
congratulated Gary Shackelford, MD, 
professor of radiology and of 
pediatrics, on being named emeritus 
professor of radiology. 
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CURRENT TOPICS IN CANCER TREATMENT 
A symposium was held on July 12 to honor 
Todd Wasserman, MD, professor of 
radiation oncology, for his outstanding 
contributions to the field of radiation 
oncology and for his many years of 
service to the Department of Radiation 
Oncology, Mallinckrodt Institute, 
Washington University, and, especially, his 
patients. The invited speakers, who 
represented some of the nation's top cancer 
centers, shared their clinical and research 
expertise in the treatment of cancer. 




At the dinner following the symposium, Amy 
and Derek Wasserman shared some amusing 
anecdotes about their father and expressed 
their pride in his accomplishments. 
Symposium attendees gathered in the Eric P. Newman Education 
Center at Washington University Medical Center to hear Charlotte 
Jacobs, MD, speak on "Todd Wasserman's achievements." 
•     • 
> 
: Wasserman (seated) received a standing 
ation from symposium attendees and speakers, 
nding directly behind Wasserman is James 
y, PhD, professor of radiation oncology and 
ief of the Department of Radiation Oncology's 
^ivision of Physics. 
David Brizel, MD, spoke on 
"Radioprotectors in oncology." 
At the close of the symposium, 
Carlos Perez, MD, chairman of 
the Department of Radiation 
Oncology, invited symposium 
guests to a reception and tour of 
the new radiation oncology facili- 
ties in the Alvin J. Siteman Cancer 
Center on the lower level of the 
Center for Advanced Medicine. 
Jeff Michalski, MD, associate 
professor of radiation oncology 
and chief of the Clinical Division 
of Washington University's 
Department of Radiation 
Oncology. 
m : - ....v.. :   .,.■ ■   m ■.  ■ ■ 
During the afternoon break, symposium speakers continued 
their discussions of advances in cancer treatment: 
(left to right) Timothy Eberlein, MD; Norman Coleman, MD; 
and Walter Curran, MD. 
At the dinner following the symposium, 
Donald Chapman, PhD, from Fox Chase 
Cancer Center in Philadelphia, presented a 
copy of the poem he wrote in honor of his 
long-time friend Todd Wasserman. Seated, 
to the right of Wasserman, is Mark 
Wrighton, PhD, chancellor of Washington 
University in St. Louis. 
THE WASSERMAN SYMPOSIUM 
CURRENT TOPICS 





CARLOS PEREZ, MD, SYMPOSIUM CHAIRMAN 
Professor and Chairman 
Department of Radiation Oncology 
Washington University 
St. Louis, Missouri 
DAVID BRIZEL, MD, PROFESSOR 
Department of Radiation Oncology 
Duke University Medical Center 
Durham, North Carolina 
NORMAN COLEMAN, MD, DEPUTY DIRECTOR 
Division of Clinical Sciences 
National Institutes of Health/National Cancer 
Center 
Bethesda, Maryland 
JAMES COX, MD, CHAIRMAN 
Department of Radiation Oncology 
M. D. Anderson Cancer Center 
Houston, Texas 
WALTER CURRAN, MD, CHAIRMAN 
Department of Radiation Oncology 
Thomas Jefferson University Hospital 
Philadelphia, Pennsylvania 
TIMOTHY EBERLEIN, MD, DIRECTOR 
Alvin J. Siteman Cancer Center 
Washington University Medical Center 
St. Louis, Missouri 
CHARLOTTE JACOBS, MD, DIRECTOR 
Clinical Cancer Center 
Stanford University Medical Center 
Stanford, California 
THEODORE PHILLIPS, MD 
Department of Radiation Oncology 
University of California 
San Francisco, California 
(Left to right) Doctors Curran, Cox, Perez, 
Jacobs, Wasserman, Phillips, and Coleman. 
giving pane 
a see munmu 
Interventional radiologists use 
two nonsurgical procedures 
to destroy tumors in the liver. 
by Barbra Rodriguez 
Brown (foreground) and 
Noah Appel, MD, clinical 
fellow in interventional 
radiology, consult during an 
RF ablation procedure. 
rteries wend their way throughout the body, where 
they serve as crucial pipelines for bringing nutrients 
and oxygen to energy-starved tissues. Yet these same vessels 
can serve a deadlier purpose by nourishing tumors that lie 
deep within the body, making them difficult to detect. 
This difficulty means tumors in the liver and certain 
other internal organs often cannot be identified until they 
are too big or too numerous to remove surgically. In recent 
years, though, several patients with liver cancer have been 
given a second chance at life as a result of Mallinckrodt 
Institute interventional radiologists' use of arteries as portals 
for delivering anti-tumor treatments. 
a second ctiance 1 
"Many patients who come to us 
for a consultation do not expect to 
live very long," says Daniel Brown, 
MD, assistant professor of radiol- 
ogy and of surgery. "Our interven- 
tional procedures are a real eye 
opener for these patients." 
Brown treats patients from all 
parts of the United States who 
need targeted treatments that leave 
most of the liver intact. Many 
patients are likely to need repeated 
treatments because they are prone 
to developing new primary hepato- 
cellular carcinomas (HCC) or 
recurrent liver metastases that 
result from gastrointestinal carci- 
noid tumors or other hormone- 
producing tumors. 
The patients benefit from a 
nonsurgical vascular approach for 
destroying tumors called 
chemoembolization or from a more 
targeted treatment called radio- 
frequency (RF) ablation that 
destroys tumor cells with current- 
induced heat. Neither approach 
radically alters nearby liver tissue, 
so the procedure can be repeated if 
necessary or can be used sequen- 
tially to the same patient. 
Michael Darcy, MD, professor 
of radiology and of surgery and 
chief of Mallinckrodt Institute of 
Radiology's (MIR's) interventional 
radiology section, began perform- 
ing chemoembolization for liver 
cancer in 1993. Brown joined the 
MIR faculty in 1999, with extensive 
experience in liver tumor 
management. 
"We are the only interventional 
radiology group in the St. Louis 
area that offers a comprehensive 
approach to cancer therapy using 
both vascular and nonvascular 
intervention," Darcy says, noting 
that patients receive the most suit- 
able approach as a result. 
chemoembolization 
With chemoembolization, a 
catheter is placed into the patient's 
femoral artery. From there, the 
catheter is selectively advanced 
into the hepatic artery, which is the 
main blood supply for the liver. A 
liquid contrast agent is injected 
into the catheter to determine how 
the blood vessels fan out into the 
liver tissue. The interventional radi- 
ologist then injects a mixture of 
drugs and embolic agents. 
An oily substance called Ethid- 
iol, which is mixed with three 
chemotherapeutic drugs, is 
injected and collects in the cancer- 
ous tissue. Because these drugs are 
injected directly into the tumor 
site, the tumor is exposed to much 
higher doses than could be 
achieved via a peripheral infusion. 
Flow into the tumor bed is 
obstructed with polyvinyl alcohol 
(PVA) particles. The combination 
of PVA and Ethiodol trap the high 
doses of chemotherapy in the liver, 
preventing systemic effects. 
Researchers have found that Ethid- 
iol can help lock drugs within the 
liver for up to a month following 
chemoembolization. 
Healthy liver tissue survives 
because another vessel, the portal 
vein, supplies blood to much of the 
organ. "You can kill the tumor with- 
out harming normal liver tissue, 
and the portal vein will take over 
the function that the hepatic artery 
can no longer do," Brown says. 
Approximately 60 percent of 
patients have the classic arrange- 
ment of blood vessels feeding the 
liver, as described in most medical 
texts. The treating physician must 
Michael Darcy, MD 
be acutely aware of any variation in 
a patient to prevent adverse out- 
comes. In particular, a physician 
must block the hepatic artery past 
a vessel that branches off to feed 
the bowel. Otherwise, the lack of 
blood flow combined with high- 
dose chemotherapy to that organ 
creates severe ulcers. 
Another issue is that patients 
with HCC have cirrhosis, a chronic 
liver disease that is often a result of 
alcohol abuse or exposure to other 
toxic chemicals. Many patients 
develop cirrhosis from viral hepati- 
tis type C or other infection. 
Regardless of the cause, the liver, 
which functions in part to process 
toxic chemicals, becomes over- 
whelmed by the insult and tries to 
repair itself by bumping up its rate 
of cell division. 
That rapid cell division 
increases the risk of some cells 
becoming the abnormal, cancerous 
cells of HCC. And it produces scar 
tissue that replaces functional tis- 
sue involved in maintaining the 
body's metabolism, blood pressure, 
and other functions. The cirrhosis 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
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leads to tumor development while 
it limits treatment options, as the 
remaining liver is severely dis- 
eased. Therefore, patients with 
HCC and cirrhosis are more at risk 
of dying if a medical procedure 
reduces remaining liver function 
too drastically. Less than 20% of 
patients are candidates for surgery. 
Although the interventional radiol- 
ogists at Mallinckrodt Institute 
have had great success with liver 
ablative techniques, patients must 
be carefully chosen to avoid treat- 
ing those patients with an inade- 
quate reserve of liver function. 
Brown and Darcy have been 
successful with chemoemboliza- 
tion and other procedures because 
of their careful selection of patients 
and their expertise with the tech- 
niques. Because of their large vol- 
ume of referred patients, Brown 
and Darcy have a better under- 
standing of the boundaries of treat- 
ment than do physicians at many 
medical centers.   "We've treated 
patients at Mallinckrodt Institute 
that other hospitals have turned 
away," Brown says. 
Under Brown's care, patients 
with HCC have lived an average of 
20 months after diagnosis. Brown, 
who leads workshops on vascular 
and interventional oncology for the 
Society of Interventional Radiol- 
ogy, notes that studies relying on 
peripheral chemotherapy or sup- 
portive management have reported 
an average survival of only three 
months. 
Patients who receive 
chemoembolization at Mallinckrodt 
Institute also benefit from staying 
only one or two days in the hospi- 
tal, as compared to the week or so 




a. There is an enhancing 10 cm hepatocellular carcinoma in the left lobe of the liver. 
b. Arteriography prior to embolization demonstrates the abnormal vessels. 
c. Follow-up CT after chemoembolization demonstrates complete tumor necrosis. 
a. Unenhanced CT demonstrates numerous large tumors in a patient with carcinoid syndrome. 
He was experiencing diarrhea several times a day as well as hot flashes, 
b and c. Early and late phase of angiography reveals the marked hypervascularity of the tumors, 
d. Following embolization the patient's symptoms resolved. 
RADIOFREQUENCY ABLATION 
Case 1 
a. Hypervascular hepatocellular carcinoma of the right lobe of the liver. 
b. The RFA needle is deployed within the tumor. 
c. Following RFA the lesion no longer enhances. Normal inflammatory response is 
identified surrounding the dead tumor. 
Case 2 
a. 4 cm hepatocellular carcinoma in the right lobe of the liver with nearby bowel 
b. Following RFA with careful needle placement, the tumor no longer enhances 
and the bowel is uninjured. 
Case 3 
a. This patient has a single metastasis to her liver after resection of breast 
carcinoma. She was not a surgical candidate for liver resection. 
b. Following RFA the entire area surrounding the tumor is necrotic. 
FOCAL SPOT, SUMMER 2002 
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a secon cR5i ance 
And patients avoid not only the 
weeks of treatment required for 
traditional chemotherapy but also 
chemotherapy's potential adverse 
effects, such as hair loss and weak- 
ened immune system function. 
Needle electrode (shown with prongs extended) 
used in radiofrequency ablation of liver tumors. 
radiofrequency ablation 
Brown also performs the RF 
ablations for liver cancer done at 
MIR. To qualify for this high-tech 
procedure, a patient must have 
three or fewer 
tumors that are 
less than 4 cen- 
timeters in size. 
The RF approach 
is favored under 
these circum- 
stances because it 
produces less tis- 
sue destruction 
and takes less 






inserts a needle 
electrode through 
a small incision in 
the skin and 
directly into the 
liver tumor. He 
then pushes a 
plunger to eject a 
series of prongs 
from the needle's 
tip that fan out 
like an umbrella 
frame. Current is 
sent into the tines 
and incites ions in 
tumor cells 
nearby to follow 
the flow of cur- 
rent. "The current 
creates friction, 





turn, creates heat. When the tem- 
perature inside the tumor cells sur- 
passes 50° Celsius, the cells begin 
to die. A much higher temperature 
— about 75° Celsius, or roughly 
167° Fahrenheit — is reached dur- 
ing RF ablation. The procedure 
takes about an hour, and patients 
can go home the same day. 
a new lease on life 
Best of all, some patients with 
HCC whose tumor burden is kept 
in check by chemoembolization 
and RF ablation may gain a new 
lease on life as a result. Eligible 
patients with HCC can remain on a 
liver transplantation list if they 
have a single tumor that is kept 
below 5 centimeters (about 2 
inches) in diameter or three tumors 
less than 3 centimeters in diameter. 
An example of this type of 
patient is Robert Brewer, a 59-year- 
old St. Louis County resident. He 
received two courses of chemoem- 
bolization and an RF ablation treat- 
ment and has remained on the 
transplantation list for 15 months. 
Diagnosed with hepatitis C in 1999, 
Brewer still suffers from joint 
aches and exhaustion but is kept 
going by his wife of 38 years, three 
children, and three grandchildren. 
Knowing that he might receive a 
liver transplant also keeps him 
motivated. "That's what it takes for 
me to live," Brewer says. 
Brown's and Darcy's ministra- 
tions have resulted in 13 patients 
with HCC taking the next step and 
receiving liver transplants in the 
past 3 years. But the benefits are 
not just for these patients. Those 
patients who have neuroendocrine 
tumors or other hormonally linked 
tumors such as insulinomas also 
benefit. In the case of gastrointesti- 
nal carcinoid tumors, patients may 
: 
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live 5 years to 10 years after 
diagnosis, thanks in part to the 
repeated removal of liver 
metastases. 
The problem is not the carci- 
noid liver tumors themselves but 
what these tumors produce: hor- 
mones such as serotonin that the 
liver can no longer degrade when 
its tumor burden becomes over- 
whelming. As a result, excess levels 
of hormone remain in the blood- 
stream, causing symptoms such as 
facial flushing and recurring bouts 
of diarrhea. 
By eliminating the liver tumors, 
Brown can keep the patient's symp- 
toms in check for a year or more 
until additional tumors crop up. 
"We can help patients take back 
some control and feel normal again 
— feel good about themselves," 
Brown says. 
additional studies 
Brown also is collaborating 
with Louis Gilula, MD, professor of 
radiology and of surgery and a 
member of MIR's musculoskeletal 
radiology section, to test RF abla- 
tion's usefulness in treating bone 
cancer. As participants in a multi- 
center trial sponsored by the Amer- 
ican College of Radiology Imaging 
Network, Brown and Gilula are 
participating in a Phase II trial to 
determine whether RF ablation 
provides a good alternative to radi- 
ation therapy for treating bone 
metastases in non-weight-bearing 
bones and the spine. The limited 
invasiveness of RF ablation and its 
ability to provide relief with a sin- 
gle treatment session may make it 
a better option for the long-term 
management of bone metastases. 
Just as with the patients 
treated by Brown and Darcy, these 
patients will have routine checkups 
that involve radiological imaging to 
detect additional or remaining can- 
cerous growths. Building long-term 
relationships with patients and 
their families is thus an important 
facet of what the physicians do. 
Brown notes that this relationship 
is also one of his most rewarding 
responsibilities. 
He says that keeping a patient's 
needs uppermost in his mind is an 
important facet of this process— 
that is why he uses RF ablation 
rather than an alternative version 
that can require four or more hos- 
pital visits to complete treatment. 
And he talks with the patient's fam- 
ily by phone whenever possible, so 
they do not have to make extra 
trips for consultation. And it is why 
he spends as much time as is nec- 
essary with patients to discuss 
their medical status, something 
Robert Brewer says he admires 
about Brown. "He's the kind of doc- 
tor who will sit down and talk with 
you and explain exactly what you 
need to do," Brewer says. 
Brown also includes humor to 
lighten conversations with families, 
who use the humor as a way of 
coping. For example, Brown often 
refers to the annual embolization in 
patients with slow-growing gas- 
trointestinal carcinoid tumors as 
the patients' "once a year tune-up," 
like the one they get for their car. 
Along with Joel Picus, MD, 
associate professor of medicine, 
Brown is studying the use of mag- 
nets to help attract chemothera- 
peutic agents to the liver. The 
drugs are attached to ferromag- 
netic particles that will be drawn 
into the liver by a magnet placed on 
a patient's abdomen, above the 
tumor. 
Brown also is involved with 
pilot research evaluating chemo- 
infusion for treating pulmonary 
metastases that are too advanced 
for traditional surgery to be effec- 
tive. The drug of choice, cisplatin, 
can produce kidney damage before 
clinical benefit is identified. And he 
is performing lab studies to deter- 
mine whether infusing high-dose 
cisplatin into the pulmonary artery 
through a balloon catheter is a bet- 
ter option. A chemical injected 
intravenously soaks up much of the 
leaked cisplatin and protects the 
kidneys. 
"The technique we use dramati- 
cally increases the level of 
chemotherapy in the pulmonary tis- 
sues," says Brown, who plans fur- 
ther studies after promising initial 
results. 
Equally rewarding to Brown 
are the relationships he has with 
colleagues from other medical 
groups and at Mallinckrodt Insti- 
tute, from secretarial staff to 
research assistants to faculty, who 
play an integral role in diagnosing 
and treating oncology patients. 
"Without the referrals from my col- 
leagues in hepatology, oncology, 
and hepatobiliary surgery, I would 
not be able to help nearly as many 
patients. Additionally, if I have a 
radiology question, I can ask the 
country's most renowned experts," 
Brown says, "whether it is interven- 
tional radiology, ultrasound, body 
imaging, or any of the other radiol- 
ogy specialties. They are all here at 
Mallinckrodt Institute." EH3 
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RADIOLOGY SERVICES 
Mallinckrodt Institute of Radiology at 
Barnes-Jewish West County Hospital 
combines quality service with easy 
access for patients. 
by Chris Wayland 
"JL l.\_x   JOL^tw/ 
From weekend warriors to couch potatoes to professional and student athletes, all types of 
patients come through Mallinckrodt Institute of Radiology's (MIR's) Diagnostic Radiology 
Department at Barnes-Jewish West County Hospital (BJWCH). The hospital is noted for excel- 
lence in orthopedics, especially sports medicine, physical rehabilitation, total joint replacement 
surgery, and spine surgery. The high level of patient service combined with the convenience of a 
community hospital and accessible parking is a top draw for patients. That good reputation 
resulted in the more than 53,000 radiology-related procedures performed last year. 
According to Robert Levitt, 
MD, director of diagnostic radiol- 
ogy at BJWCH, patient services 
fall into three main categories: 
outpatient diagnostics, outpatient 
therapeutics and outpatient/ 
short-stay surgeries. 
In the short-stay surgery 
category, sports injuries and degen- 
erative joint and spine disease 
result in many hospital admissions 
for surgical repair or replacement 
of joints or spinal surgery, but the 
hospital performs a host of other 
specialized surgeries including 
cosmetic, eye, general, and uro- 
logic surgery. 
"Many patients, with the rec- 
ommendation of their physicians, 
are opting for outpatient surgeries," 
says Levitt. "Our hospital staff 
includes Washington University 
surgeons as well as surgeons in 
private practice, such as the 
physicians at Missouri Bone and 
Joint and The Orthopedic Center of 
St. Louis. All of these groups have 
offices on the hospital campus." 
And technology keeps the pace 
moving briskly. "We have the 'latest 
and greatest' of radiological equip- 
ment," Levitt notes. 
Left: One control room serves both magnetic resonance 
imaging (MRI) and computed tomography (CT). 
Tracy Land, RT, a medical imaging technologist, is 
shown in the CT area. The opposite side of the room 
accommodates MRI. 
Radiology services include 
magnetic resonance imaging (MRI), 
bone densitometry, computed 
tomography (CT), ultrasound, and 
mammography. Fluoroscopic 
rooms are available for barium 
studies and special procedures, 
such as MR arthrography (injecting 
a substance into a joint space, 
which outlines that area on MR 
images). Nuclear radiology is also 
available, including bone scans to 
test for metastatic disease in 
patients with cancer, thyroid scans 
to check for nodules, myocardial 
scans to evaluate coronary artery 
disease, hepatobiliary imaging to 
assess gallbladder 
function, and lung 
scans to check for 
pulmonary emboli. 
The volume of 
tests translates into 
thousands of radiol- 




decreased the time 
required by doctors 
to prepare the 
reports and has made 
report transmission 
easier and faster. 
Voice-recognition 
dictation systems type out the 
report as the physician speaks. A 
signed report that once took hours 
w%W%l!lll I IwllJ 
The radiologists on staff at BJWCH are 
Washington University physicians who are 
faculty members of the world-renowned 
Mallinckrodt Institute of Radiology. 
• Joanna Costello specializes in magnetic 
resonance and orthopedics. 
• William James, Mary Middleton, 
and Levitt are general diagnostic 
radiologists. 
• Alan Williams, a neuroradiologist in the 
neuroradiology section at MIR, and 
David Rubin, William Totty, and William 
Reinus, all of the musculoskeletal 
section at MIR, provide on-site specialty 
interpretations at BJWCH. 
According to Levitt, the combination of 
generalists and subspecialists in the 
radiology department at BJWCH is key to 
delivering the high level of professional 
services expected by referring physicians. 
"It is that combination that explains 
the success of our radiology 
at BJWCH," he says. 
William James, MD, instructor in radiology, dictates a 
case, using the voice-recognition system. 
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to complete now can be 
done in five minutes, 
Levitt says. 
Patient care is 
enhanced by the use of 
a Picture Archiving and 
Communication System 
(PACS). Many of the 
tests, such as nuclear 
medicine, CT, ultra- 
sound, and MRI can be 
transmitted electroni- 
cally among hospitals in 
the BJC HealthCare™ 
system as well as physician offices. 
"PACS is a series of computers 
designed to store and display diag- 
nostic images," explains David 
Melson, MIR's manager of imaging 
applications. "By providing on-line 
access to both current and prior 
studies, PACS enables the radiol- 
ogy department to work more 
efficiently. Referring physicians 
will also have access to the images 
electronically, using a BJC applica- 
The Imaging Center offers easy access for all patients. 
[easy 
tion called Clinical Desktop that 
links the referring physician's 
computers to an MIR image server. 
These factors lead to better service 
for referring physicians and, 
ultimately, better patient care". 
Using teleradiology, MIR 
radiologists at BJWCH can inter- 
pret imaging studies 24 hours a 
day, seven days a week. The 
images can be sent electronically 
to a radiologist's home computer 
or laptop. After interpreting the 








proud of The 
BJWCH Imaging 
Center (at 969 
Mason Road, 
across the 
street from the 
hospital) that 
opened in Octo- 
ber 2001. It is 
equipped with leading-edge tech- 
nology, including a state-of-the-art 
spiral CT scanner with 3-D imaging 
capabilities that can help detect 
conditions such as coronary artery 
disease through calcium scoring 
and lung carcinoma by thin section 
examination of the lung fields. 
Magnetic resonance imaging, 
plain film X rays, and ultrasound are 
also available at the Imaging Center. 
Many physicians have their offices 
in the Imaging Center, which is also 
equipped with a computerized read- 
ing room. When a patient comes to 
the Imaging Center, physicians can 
access the patient's previous test 
results from Barnes-Jewish Hospital 
(BJH) at Washington University 
Medical Center, BJWCH, or the 
Imaging Center by using PACS. The 
radiologist can then view the past 
and current tests and compare them 
side-by-side on the computer moni- 
tor. The findings of the new test 
are dictated into the voice-activated 
typing system, and the report is 
archived. Once the test is in the 
PACS system, it can be read at 
either BJH, BJWCH, or the 
Imaging Center. 
Other facilities on the BJWCH 
campus include physicians' office 
buildings (POBs): POB 1 houses 
private practice and Washington 
University-affiliated physicians in 
the specialties of urology, cosmetic 
surgery, allergy/immunology, pul- 
monary medicine, ophthalmology, 
pain management, and dermatol- 
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ogy. POB 2 houses Missouri Bone 
and Joint and The Orthopedic 
Center of St. Louis, both private- 
practice groups specializing in 
orthopedic and spine surgery. In 
POB 3 is The Heart Care Institute, 
staffed by Washington University 
cardiologists, and the Washington 
University orthopedic and spine 
surgery offices. 
Due to the popularity of 
BJWCH, the demand for operating- 
room time has outstripped the 
capacity of existing operating 
rooms. An outpatient Ambulatory 
Surgery Center, slated to open in 
the spring of 2003, will double the 
hospital's number of operating 
rooms. 
Levitt is proud of BJWCH and 
the services MIR offers to the 
hospital's patients. "We are able to 
provide the expertise of an acade- 
mic center in a community setting", 
he says, and emphasizes that 
everyone at BJWCH—administra- 
tors, Washington University 
physicians, private physicians, and 
hospital staff— have a common 
goal: to provide the highest quality 
clinical care in a compassionate 
community-hospital setting. DEI 
Levitt, who was named director of diagnostic radiol- 
ogy at BJWCH in 1990, meets with a patient who is 
scheduled to undergo a lumbar spine series. 
service] 
Far Left: Levitt (right) and Daniel Gaitan, MD, an 
endocrinologist, review a current case. 
Left Center: Joanna Costello, MD, instructor in 
radiology, is shown in the MRI procedure area. 
Left: Mary Middleton, MD, assistant professor of 
radiology, reviews CT cases with David Johnston, 
MD, a third-year diagnostic radiology resident. 
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A HISTORY OF. t innovation AND 
quality patient care 
The CT/PET scanner 
allows physicians to 
see both the function 
and precise location 
of a lesion in a single 
study. Photo cour- 
tesy of Siemens Med- 
ical Solutions. 
BY CANDACE O'CONNOR 
I 
MOST PATIENTS  LOOKING  FOR  HEALTH CARE 
EXPECT TOP QUALITY CARE AND EXPERI- 
ENCED PHYSICIANS. THEY SHOULD EXPECT NO LESS 
FROM A DIAGNOSTIC  IMAGING  FACILITY. AT THE 
CLINICAL PET CENTER, PATIENTS HAVE THE 
ADVANTAGE OF WASHINGTON  UNIVERSITY 
NUCLEAR  MEDICINE  PHYSICIANS, WHO ARE 
AFFILIATED WITH THE WORLD-RENOWNED 
MALLINCKRODT INSTITUTE OF  RADIOLOGY (MIR) 
AND THE TOP-RANKED BARNES-JEWISH  HOSPI- 
TAL (BJH). THESE PHYSICIANS COLLECTIVELY 
HAVE OVER 145 YEARS OF EXPERIENCE IN 
NUCLEAR MEDICINE AND 50-PLUS YEARS IN 
POSITRON EMISSION TOMOGRAPHY (PET) IMAGING. 
MORE THAN 2,400 COMPREHENSIVE DIAGNOSTIC 
PET EXAMINATIONS ARE PERFORMED ANNUALLY. AND 
THIS COMBINATION TRANSLATES  INTO A MORE 
ACCURATE  DIAGNOSIS AND A SMOOTHER PROCESS  FOR THE 
PATIENT AND THE REFERRING  PHYSICIAN. 
The Institute has been 
a leader in PET technology since 
the early 1970s, when a team of 
MIR researchers, led by Michel Ter- 
Pogossian, PhD, developed the first 
useable PET device for human 
studies. A broad PET research pro- 
gram followed. And in 1989, MIR 
opened the first clinical PET facil- 
ity in Missouri and one of the first 
three in the United States. In 1992 
BJH took over the technological 
operations of the Clinical PET Cen- 
ter; MIR's Division of Nuclear Med- 
icine continued to staff the facility. 
In October 2002, the Clinical 
PET Center will mark an exciting 
new milestone: the arrival of the 
first combined PET/CT (computed 
tomography) scanner in the 
St. Louis metropolitan area. 
Already, the Center has two 
dedicated PET scanners that are 
heavily used. But this new scanner, 
which Time magazine called in 
2000 "the invention of the year," 
represents a major technological 
breakthrough. 
"The Biograph" PET/CT scan- 
ner, which also incorporates a new 
type of radiation detectors, will 
offer a faster imaging time and 
better images," says Barry Siegel, 
MD, professor of radiology and of 
medicine and director of the 
Division of Nuclear Medicine. "It 
will give us the ability to fuse 
anatomical data from the CT scan- 
ner directly with metabolic data 
from the PET scanner, making 
image interpretation better and the 
data much easier to use." 
For patients with cancer, that 
will translate into even better care. 
It is critically necessary for physi- 
cians to accurately localize lesions 
in these patients, says Farrokh 
Dehdashti, MD—but comparing 
PET and CT images side-by-side 
has never been as easy or as accu- 
rate as physicians would like. Now 
the merged images supplied by the 
PET/CT scanner will allow the 
medical team to improve detection 
and localization of disease and bet- 
ter direct biopsy or therapy. 
"PET/CT scanners have been 
shown to be twenty percent more 
accurate for disease detection than 
is PET imaging alone," says 
Dehdashti, associate professor of 
radiology. "The use of these scan- 
ners is expected to reduce the 
number of invasive and noninva- 
sive procedures in evaluating 
patients with cancer." 
Barry Siegel, MD 
BURGEONING 
CLINICAL USES 
This new technology is bolster- 
ing a field in which the clinical 
applications of PET, a tool that 
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THE CLINICAL PET CENTER 
Farrokh Dehdashti, MD 
assesses biochemical processes in 
patients and produces functional 
images of metabolic activity, have 
steadily increased over the past 
decade. With their first PET scan- 
ner—the Super PETT-IIB, built at 
Washington University by Ter- 
Pogossian in the mid-1980s for 
research and later converted to 
clinical use—Siegel and the nuclear 
medicine team began by focusing 
on images of the brain and heart. 
But this early scanner only 
allowed physicians to view the 
metabolic activity in a limited area 
of the body. Then new equipment 
came on the market that provided 
many imaging slices at once over a 
larger area of the body. In 1991, 
Siegel's group bought a scanner 
from CTI, Inc., the ECAT EXACT. 
MIR's nuclear medicine faculty, in 
collaboration with CTI scientists, 
developed practical techniques and 
the necessary software for whole- 
body imaging. 
These technological advance- 
ments allowed MIR's Division of 
Nuclear Medicine to move into the 
field of oncology; early work 
involved scanning of soft-tissue 
sarcomas, deciding whether a mass 
was malignant, and identifying the 
best place to biopsy. Lung-cancer 
applications were developed, as 
PET was used to distinguish benign 
from malignant lung nodules and to 
detect metastatic deposits. 
"Over the years, PET has 
slowly grown into a technique that 
is used for diagnosis, staging, 
restaging, and, most recently, treat- 
ment monitoring for a wide variety 
of cancers," says Siegel, who cur- 
rently chairs the Institute of Clini- 
cal PET Council of the Academy 
for Molecular Imaging. 
Today at Mallinckrodt Insti- 
tute, PET is used clinically in many 
forms of cancer: cervical, colorec- 
tal, esophageal, head and neck, 
lung, malignant melanoma, lym- 
phoma, and breast, especially 
recurrent and distant metastatic 
disease. Recently, in collaboration 
with the University of Michigan and 
Duke University, Siegel's group 
completed a large clinical trial to 
study the effectiveness of PET in 
evaluating the axillary lymph nodes 
of women with breast cancer. 
"Particu- 
larly in the field 
of oncology, 
there are sev- 
eral research 
studies unique 
to our institu- 
tion," says 
Dehdashti, 
"such as PET 
imaging of 
estrogen recep- 
tors in breast 
cancer, andro- 





tance in a vari- 
ety of cancers. 
We are also involved in several 
multicenter clinical trials, such as 
those evaluating the uses of PET in 
lung and esophageal cancers." 
Historically, MIR's nuclear 
medicine physicians have believed 
so strongly in this research that 
they have provided many of these 
scans free-of-charge. Mallinckrodt 
Institute and Barnes-Jewish Hospi- 
tal have underwritten scans, and 
continue to do so, when Medicare 
or insurance companies refused to 
cover them and patients could not 
afford to pay. "We don't turn 
patients down for appropriately 
indicated studies," says Siegel. 
INCREASING DEMAND 
Over the past several years, the 
eight-member nuclear medicine 
team has seen its PET workload 
increase dramatically. In 1989, 
around 100 studies were performed 
altogether; now the average is 10 to 
12 per day. Patient totals have been 
rising at a rate of 30 percent to 40 
percent annually. 
As other PET centers open in 
the region, those physicians often 
come to Mallinckrodt Institute for 
training, because of MIR's reputa- 
tion in this field. "We have been 
I 
The Siemens Biograph  CT/PET scanner can 
significantly reduce scan time and enhance cancer 
treatment and detection. Photo courtesy of Siemens 
Medical Solutions. 
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working with PET for a long time, 
and we devote a lot of time to it," 
Siegel says. "This experience and 
dedication translates into highly 
trained physicians and technolo- 
gists who screen examinations 
carefully, assuring that the PET 
study we are going to do is sensible 
and answers the question the refer- 
ring physician is asking. We make 
sure that we have anticipated every 
possible problem." 
The Clinical PET Center's two 
existing PET units (the ECAT 
EXACT and the more recently 
acquired C-PET) are located on 
MIR's seventh floor. When the 
PET/CT scanner arrives, it will be 
installed in the radiology area adja- 
cent to the new Center for 
Advanced Medicine and the Site- 
man Cancer Center. There are four 
other PET scanners around the 
medical center, all owned by Wash- 
ington University and all used for 
research: a scanner on the seventh 
floor for cancer and cardiac stud- 
ies; another in the neurological 
intensive care unit for brain 
research, often in cases of head 
injury or stroke; a third, also for 
brain studies, in the East Building; 
and a fourth, a micro-PET scanner 
for imaging laboratory rodents, in 
the Clinical Sciences Research 
Building. 
MIR also owns three 
cyclotrons—and that is a bonus for 
the Institute's PET program. While 
other PET centers must buy com- 
mercially marketed fluo- 
rodeoxyglucose (FDG), the main 
radiopharmaceutical used in PET 
studies, Siegel's group has FDG 
prepared on campus. 
USING PET IN CERVICAL 
CANCER CASES 
Perry Grigsby, MD, is one of 
the physicians who refers patients 
to the nuclear medicine group for 
PET evaluation. Most of his prac- 
tice involves gynecologic cancers, 
especially cancer of the cervix. 
When these women come to him 
for treatment, Grigsby must first 
evaluate where the cancer is and 
how far it has spread. Is it limited 
to the cervix? Or has it moved into 
the pelvic lymph nodes, para-aortic 
lymph nodes, or other sites? 
For the past four years, PET 
has been used to make most of 
these determinations. Before then, 
the gynecologic oncology team 
used other imaging tools, such as 
CT. "PET has been advantageous 
because it is better at showing the 
tumor spread than are other modal- 
ities," says Grigsby, professor of 
radiation oncology and of radiol- 
ogy. "It is fair to say that from one 
quarter to one half of women with 
cervical cancer have had their 
treatments changed because of 
PET. It has had a great impact." 
THE FUTURE 
As Siegel sees it, PET has a 
bright future. In the past, small- 
scale studies had already shown 
that PET prevented some 10 per- 
cent to 15 percent of unnecessary 
surgeries in patients with lung can- 
cer. Now a larger, rigorously con- 
trolled study from the Netherlands 
has indicated that those figures 
may be too low—that PET is even 
more effective than previously 
thought. 
PET has some limitations, 
Siegel admits. It has limited appli- 
cation in prostate cancer, for exam- 
ple, and is not yet fully accurate in 
determining whether a suspicious 
breast mass is malignant. New 
radiopharmaceutical "tracers" used 
in PET scans, some of them in 
development at Washington Uni- 
versity, may open avenues for PET 
in these areas. Meanwhile, Siegel 
and others have also been active in 
urging Medicare, which currently 
pays for some PET exams, to cover 
more kinds of studies. 
But overall, there is no longer 
any question as to PET's clinical 
utility. "At this point, the PET and 
oncologic communities are con- 
vinced that PET should be a gener- 
ally available imaging tool for 
problem-solving in patients with 
cancer," says Siegel. "We will still 
want to use MRI [magnetic reso- 
nance imaging] or CT for certain 
things, but it is clear that, for initial 
staging of most cancers, PET is bet- 
ter than CT and MR, and is the test 
that should be used." 
In the future, Mallinckrodt 
Institute's PET program is likely to 
continue expanding. Siegel is 
already looking toward the next 
generation of PET/CT scanners, 
with a larger imaging field and dif- 
ferent design. For patients, that will 
mean a faster exam—perhaps 15 
minutes or less, as compared to the 
current 45 minutes to an hour. A 
Perry Grigsby, MD 
new micro-PET scanner may also 
be in the offing. 
"PET is our premier metabolic 
imaging tool, and the paradigm of 
the coming era of molecular imag- 
ing," says Siegel. EH 
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A SON'S TRIBUTE 
ART IS A LANGUAGE, 
AN EXPRESSION OF 
LIFE THAT EASES THE 
MIND AND COMFORTS 
THE SOUL, MUCH IN 
THE WAY MY FATHER'S 
COMPASSIONATE 
CARE FOR HIS 
PATIENTS COMFORTED 
THEIR BODIES. 
Ian Gilula is a soft-spoken, contemplative young man 
whose hidden strength and passion is revealed in his artistic creations. 
One of his most cherished works is housed in the Eric P. Newman 
Education Center on the Washington University Medical Center campus. 
The 800-pound monolith is a tribute to Ian's father, Dr. Louis Gilula, 
professor of radiology and of surgery and a member of Mallinckrodt 
Institute's musculoskeletal radiology section. 
At the dedication on June 17—appropriately, the Monday following 
Father's Day—William Peck, MD, executive vice chancellor for medical 
affairs and dean of the School of Medicine, said that the pink granite 
monolith makes a "strong statement, indicative of Louis Gilula and of 
Washington University School of Medicine." 
According to Ian, his monolith was inspired by the ancient Mayan stela, 
an upright slab of stone with a low-relief carving found in or near temples 
throughout the Yucatan Peninsula. Stelas served as storyboards for the 
3,000-year-old Mayan civilization. 
"Art is a language, an expression of life that eases the mind and com- 
forts the soul, much in the way my father's compassionate care for his 
patients comforted their bodies," Ian says. 
He hopes this monolith, his stela, will be a modern-day storyboard, a 
tribute to the work ethic, the compassion, and the dedication of his father, 
Louis Gilula. 
Dean William Peck (right) commended Dr. Louis Gilula for his 
many contributions to the care of patients at Washington 
University Medical Center. 
Molten glass, which was cast and created by 
Ian Gilula at Alfred University School of Art 
and Design in New York, is infused into 
carved spaces on the front of the monolith. : 
— 
In honor of Louis A. Gilula, M. 
His years of service and many contributions to 
Washington University School of Medicine. 
Will iiii 
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Louis and Ian Gilula 
In this section, the names of employees who are full-time 
faculty or staff or who have an appointment in the 
Department of Radiology or Department of Radiation 
Oncology are highlighted in boldface type. 
CHANGE IN 
STATUS  
Gary Shackelford, MD, 
professor of radiology and 
of pediatrics, was appointed 
emeritus professor of 
radiology. 
PROMOTIONS 
Sanjeev Bhalla, MD, 
instructor in radiology, was 
promoted to assistant pro- 
fessor of radiology, Division 
of Diagnostic Radiology, 
Department of Radiology. 
Joanna Costello, MD, 
instructor in radiology, was 
promoted to assistant pro- 
fessor of radiology, Division 
of Diagnostic Radiology, 
Department of Radiology. 
William James, MD, 
instructor in radiology, was 
promoted to assistant pro- 
fessor of radiology, Division 
of Diagnostic Radiology, 
Department of Radiology. 
Richard Kronemer, MD, 
instructor in radiology, was 
promoted to assistant pro- 
fessor of radiology, Division 
of Diagnostic Radiology, 
Department of Radiology. 
Gary Luker, MD, instructor 
in radiology, was promoted 
to assistant professor of 
radiology, Division of 
Diagnostic Radiology, 
Department of Radiology. 
Christine Menias, MD, 
instructor in radiology, was 
promoted to assistant pro- 
fessor of radiology, Division 
of Diagnostic Radiology, 
Department of Radiology. 
NEW FACULTY 
Wenhua Chu, PhD, 
research instructor in radiol- 
ogy, Division of Radiological 
Sciences, Department of 
Radiology. 
Michael Gelbart, MD, 
instructor in radiology, 
Division of Diagnostic 
Radiology, Department of 
Radiology. 
Richard Kraus, MD, 
assistant professor of radiol- 
ogy, Division of Diagnostic 
Radiology, Department of 
Radiology. 
Robert Mach, PhD, profes- 
sor of radiology, Division of 
Radiological Sciences, 
Department of Radiology. 
Vamsidhar Narra, MD, 
assistant professor of radiol- 
ogy, Division of Diagnostic 
Radiology, Department of 
Radiology. 
Mehdi Poustchi-Amin, MD, 
instructor in radiology, 
Division of Diagnostic 
Radiology, Department of 
Radiology. 
Zhude Tu, PhD, MD, 
research instructor, Division 
of Radiological Sciences, 
Department of Radiology. 
Pamela Woodard, MD, 
assistant professor of radiol- 
ogy, Division of Diagnostic 




Ajeet Gordhan, MD, clini- 
cal fellow in neuroradiology, 
received an undergraduate 
degree and a medical degree 
from the University of 
Witwatersrand. He com- 
pleted an internship and a 
residency at Saint Louis 
University. 
Steven Hong, MD, clinical 
fellow in abdominal radiol- 
ogy, received an undergradu- 
ate degree from Yale 
University and a medical 
degree from Baylor College 
of Medicine. He completed 
an internship and a resi- 
dency at Baylor College of 
Medicine. 
Robert Lesniak, MD, 
clinical fellow in interven- 
tional radiology, received an 
undergraduate degree from 
St. Norbert College and a 
medical degree from the 
Medical College of 
Wisconsin. He completed 
an internship at St. Luke's 
Medical Center and a resi- 
dency at the Medical College 
of Wisconsin. 
Archie McGowan, MD, 
clinical fellow in neuroradi- 
ology, received an under- 
graduate degree from the 
University of Pennsylvania 
and a medical degree from 
Dartmouth. He completed an 
internship at Mt. Auburn 
Hospital and a residency at 
Brigham and Women's 
Hospital. 
Jordan Page, DO, clinical 
fellow in neuroradiology, 
received an undergraduate 
degree from the University 
of Missouri at Kansas City 
and a medical degree from 
The University of Health 
Sciences—College of 
Osteopathic Medicine. He 
completed an internship at 
Capital Region Medical 
Center and a residency at 
the University of Missouri, 
Kansas City. 
Mandar Pattekar, MD, 
clinical fellow in abdominal 
radiology, received an 
undergraduate degree from 
the University of Iowa and a 
medical degree from Krishn 
Institute of Medical 
Sciences. He completed an 
internship and a residency a 
William Beaumont Hospital 
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I Michael Rodriguez, MD, clinical fellow in interven- 
tional radiology, received an 
undergraduate degree and a 
medical degree from the 
University of South Florida. 
He completed an internship 
at the University of Texas, 
Galveston, and a residency 
at the University of Texas, 
Houston. 
Mehrdad Sehizadeh, MD, 
clinical fellow in neuroradi- 
ology, received an under- 
graduate degree from the 
Gifted Children Educational 
Center and a medical degree 
from Tehran University of 
Medical Sciences. He 
completed an internship at 
Detroit Medical Center and 
a residency at Henry Ford 
Hospital. 
Lina Sierra Sierra, MD, 
clinical fellow in abdominal 
radiology, received a med- 
ical degree from the 
Universidad Pontificia 
Bolivariana. She completed 
an internship at Clinica 
Leon XIII and a residency 
at Instituto de Clencias de 
la Salud. 
Paula Slack, DO, clinical 
fellow in breast imaging, 
received an undergraduate 
degree from Washington 
State University and a 
medical degree from Des 
Moines University. She 
completed an internship and 
a general surgery residency 
at Doctor's Hospital, 
Columbus, and a diagnostic 
radiology residency at 
Botsford Hospital. 
Susannah Thurman, DO, 
clinical fellow in breast 
imaging, received an under- 
graduate degree from 
Southwest Missouri State 
University and a medical 
degree from The University 
of Health Sciences—College 
of Osteopathic Medicine. 
She completed an internship 
and a residency at Doctors 
Hospital. 
John Yu, MD, clinical 
fellow in abdominal radiol- 
ogy, received an undergradu- 
ate degree and a medical 
degree from the University 
of Ottawa. He completed an 
internship at The Ottawa 
Hospital 
NEW RESIDENTS 
Heather Byer, MD, 
assistant in radiology, is a 
second-year diagnostic 
radiology resident. She 
received an undergraduate 
degree from the College of 
William and Mary and a med- 
ical degree from Georgetown 
University. Byer completed 
an internship and one-year 
of diagnostic radiology 
training at Georgetown 
University. 
Timothy Smullen, MD, 
assistant in radiology, is a 
second-year diagnostic radi- 
ology resident. He received 
an undergraduate degree 
from Miami University, 
Oxford, and a medical 
degree from Ohio State 
University. Smullen com- 
pleted an internship at 
Riverside Hospital and one 
year of diagnostic radiology 






Scott Bolton, MD, assistant 
in radiology, received an 
undergraduate degree from 
Auburn University and a 
medical degree from Johns 
Hopkins University School 
of Medicine. He completed a 
one-year internship at 
Barnes-Jewish Hospital. 
David Chang, MD, assistant 
in radiology, received an 
undergraduate degree from 
Yale University and a med- 
ical degree from Stanford 
University. He completed an 
internship at Yale—New 
Haven Hospital. 
Wincha Chong, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
Brown University and a med- 
ical degree from Washington 
University in St. Louis. She 
completed a transitional 
residency program at the 
University of Hawaii. 
James Colonnello, MD, 
assistant in radiology, 
received an undergraduate 
degree from the University 
of California, Davis, and a 
medical degree from Saint 
Louis University. He 
completed an internship at 
Loyola University. 
Ryan Cook, MD, assistant 
in radiology, received an 
undergraduate degree from 
Brigham Young University 
and a medical degree from 
Saint Louis University. He 
completed an internship at 
St. Mary's Health Center. 
Michelle Dorsey, MD, 
assistant in radiology, 
received an undergraduate 
degree and a medical degree 
from the University of 
Wisconsin. She completed 
an internship at St. Luke's 
Medical Center. 
Nelson Elkins, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
the University of Texas, 
Austin, and a medical degree 
from Texas Tech University. 
He completed an internship 
at Presbyterian Hospital. 
Sean Higginson, MD, assis- 
tant in radiology, received an 
undergraduate degree from 
Wilkes University and a med- 
ical degree from the Medical 
College of Pennsylvania— 
Hahnemann University. He 
completed an internship at 
Chestnut Hill Hospital. 
Jason Kerr, MD, assistant 
in radiology, received an 
undergraduate degree from 
Brigham Young University 
and a medical degree from 
the University of California, 
San Francisco. He com- 
pleted an internship at the 
Mayo Clinic, Scottsdale. 




Continued from page 23 
Yuliya Lakhman, MD, 
assistant in radiology, 
received an undergraduate 
degree from New York 
University and a medical 
degree from Johns Hopkins 
University. She completed 
an internship at the 
University of Washington. 
Kevin Lee, MD, assistant in 
radiology, received an 
undergraduate degree from 
Pomona College and a med- 
ical degree from Washington 
University in St. Louis. He 
completed an internship at 
Barnes-Jewish Hospital. 
Judy Liu, MD, assistant in 
radiology, received an under- 
graduate degree from the 
University of California, 
Los Angeles, and a medical 
degree from Washington 
University in St. Louis. She 
completed an internship at 
Arrowhead Regional Medical 
Center. 
Ryan Murtagh, MD, assis- 
tant in radiology, received an 
undergraduate degree and a 
medical degree from the 
University of South Florida. 
He completed an internship 
at Barnes-Jewish Hospital. 
Ashesh Parikh, MD, assis- 
tant in radiology, received an 
undergraduate degree and a 
medical degree from 
Northwestern University. He 
completed an internship at 
the University of California, 
San Francisco. 
Creed Rucker, MD, assis- 
tant in radiology, received an 
undergraduate degree and a 
medical degree from the 
University of Arizona. He 
completed one year of a 
surgery residency at 
Vanderbilt University. 
Karun Sharma, MD, PhD, 
assistant in radiology, 
received an undergraduate 
degree from the College of 
William and Mary. He 
received a medical and a 
doctoral degree from the 
Medical College of Virginia. 
Sharma completed a two- 
year internship at the 
Medical College of Virginia. 
Krishna Thirumala, MD, 
assistant in radiology, 
received an undergraduate 
degree from Duke University 
and a medical degree from 
the University of Alabama. 
He completed an internship 
at Baptist Hospital. 
Daniel Wessell, MD, PhD, 
assistant in radiology, 
received an undergraduate 
degree and two masters 
degrees from North Carolina 
State University. He received 
a medical degree and a 
doctoral degree from the 
University of North Carolina. 
Wessell completed an 





Brock McDaniel, MD, 
assistant in radiology, 
received an undergraduate 
degree from California State 
Polytechnic University and 
a medical degree from the 
Medical College of 
Wisconsin. He completed 
an internship and a resi- 
dency at the University of 
New Mexico Health Sciences 
Center. 
Christian Schmitt, MD, 
assistant in radiology, 
received an undergraduate 
degree from the University 
of Missouri, Columbia, and a 
medical degree from Saint 
Louis University. He com- 
pleted an internship at Saint 
Louis University and a resi- 
dency at the University of 
South Florida. 
Jayson St. Jacques, MD, 
assistant in radiology, 
received an undergraduate 
degree from Boston 
University and a medical 
degree from the American 
University of the Caribbean. 
He completed an internship 
at the Hospital of St. Raphael 






Lilie Lin, MD, assistant in 
radiation oncology, received 
an undergraduate degree 
and a medical degree from 
Washington University in 
St. Louis. 
Parag Jitendra Parikh, MD, 
assistant in radiation oncol- 
ogy, received an undergradu- 
ate degree from Case 
Western Reserve University 
and a medical degree from 
Washington University in 
St. Louis. 
Catherine Wu, MD, assis- 
tant in radiation oncology, 
received an undergraduate 
degree and a medical degree 
from Washington University 
in St. Louis. 
JOINT 
APPOINTMENTS 
Randy Buckner, PhD, 
associate professor of psy- 
chology and of anatomy and 
neurobiology, was appointee! 
associate professor of radio! 
ogy, Division of Radiologica 
Sciences, Department of 
Radiology. 
Perry Grigsby, MD, profe: 
sor of radiation oncology, 
was appointed professor ol 
radiology, divisions of 
Nuclear Medicine and 
Radiological Sciences, 
Department of Radiology. 




Samuel Achilefu, PhD, 
associate professor of 
radiology, as principal 
lvestigator, received a 
$454,938 grant from the U.S. 
tepartment of Defense to 
study "Optical imaging of 
mammoglobin expression in 
breast cancer." Coinvestiga- 
tors are Timothy Fleming, 
research associate pro- 
fessor of surgery; John 
Schotland, MD, PhD, asso- 
ciate professor of electrical 
engineering and assistant 
professor of radiology; and 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy. As principal investiga- 
tor, Achilefu received a 
Siteman Cancer Center 
Development Project grant 
of $20,000 for research on 
"Site-specific stealth molecu- 
lar beacons for imaging 
cathepsin D expression in 
tumor cells." Schotland and 
Achilefu, as principal 
investigators, received a 
Washington University 
Molecular Imaging Center 
Pilot Research Award of 
$19,714 for research on 
"Receptor-specific Tat- 
peptide conjugates." 
Jeffrey Bradley, MD, assis- 
tant professor of radiation 
oncology, received a one- 
year Barnes Research 
Development Award of 
$15,250 to study FDG-PET 
registration with treatment 
planning CT scans. 
David Gierada, MD, assis- 
tant professor of radiology, 
received a $12.4 million 
contract from the National 
Cancer Institute for the 
National Lung Screening 
Trial (NLST), which will 
measure lung cancer detec- 
tion rates of single-view X 
ray as compared to spiral 
computed tomography. The 
Mallinckrodt Institute con- 
tract is part of a larger 
Washington University con- 
tract coordinated by Gerald 
Andriole, MD, who is head of 
the preventive cancer 
research organization PLCO 
(prostate, lung, colon, and 
ovarian). Andriole is princi- 
pal investigator for PLCO 
and for NLST; Gierada is 
NLST leader and co-principal 
investigator. 
Bonnie Joe, MD, PhD, 
clinical fellow in magnetic 
resonance imaging, received 
a Radiological Society of 
North America Fellowship 
grant of $50,000 for research 
on "Evaluation of MR con- 
trast enhancement and MRS 
in breast cancer: effect of 
contrast injection rate and 
effect of contrast on MRS 
profile." 
Mark Mintun, MD, profes- 
sor of radiology, as principal 
investigator, received a 
$200,000 grant from the 
National Institutes of Health 
for research on "Nicotine- 
induced dopamine changes 
in addicted smokers." 
Bruce Whiting, PhD, 
research assistant professor 
of radiology, as principal 
investigator, received a 
$382,813 grant from the 
National Cancer Institute for 
research on "Radiation dose 
reduction in X-ray computed 
tomography." Coinvestiga- 
tors for the two-year grant 
are Kyongtae Bae, MD, 
PhD, assistant professor of 
radiology; Steven Don, MD, 
assistant professor of radiol- 
ogy; Charles Hildebolt, 
DDS, PhD, associate profes- 
sor of radiology; and 
Benjamin Lee, MD, associ- 
ate professor of radiology. 
Jie Zheng, PhD, research 
assistant professor in radiol- 
ogy, as principal investiga- 
tor, received a $121,000 
grant from the American 
Heart Association (Heartland 
Affiliate) for research on 
"Myocardial flow reserve 
measurement by magnetic 
resonance imaging: a BOLD 
approach." Coinvestigators 
are Robert J. Gropler, MD, 
associate professor of radiol- 
ogy, of medicine, and of 
biomedical engineering; 
Dmitriy Yablonskiy, PhD, 
assistant professor of 
radiology; Dana 
Abendschein, PhD, 
Department of Internal 
Medicine; Pamela 
Woodard, MD, assistant 
professor of radiology; 




Colin Derdeyn, MD, asso- 
ciate professor of radiology, 
was elected to a one-year 
term as chair of the 
Nominating Committee of 
the American Society of 
Interventional and 
Therapeutic Neuroradiology 
and was appointed to a one- 
year term on the Society's 
Executive Committee. He 
was appointed to a two-year 
term on the Research 
Committee of the American 
Society of Neuroradiology 
and to a two-year term on 
the Membership/Credentials 
Committee of the American 
Heart Association Stroke 
Council. 
Dione Farria, MD, MPH, 
assistant professor of radiol- 
ogy, was appointed chair 
of the American College 
of Preventive Medicine 
Mentorship Program, Young 
Physician's Section. She was 
appointed adjunct assistant 
professor of community 
health, Saint Louis 
University School of Public 
Health, St. Louis, Missouri. 
Louis Gilula, MD, profes- 
sor of radiology and of 
surgery, was appointed as an 
musculoskeletal examiner 
for the American Board of 
Radiology's oral boards held 
in Louisville, Kentucky, 
June 9-12. 
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Jay Heiken, MD, professor 
of radiology, chief of 
abdominal imaging, and 
codirector of body computed 
tomography, was appointed 
moderator of the plenary 
session on "Abdominal MRI" 
and as a member of the 
Unknown Film Reading 
Panel for the Abdominal 
Radiology Course 2002. The 
meeting, which was spon- 
sored by the Society of 
Gastrointestinal Radiologists 
and the European Society of 
Gastrointestinal and 
Abdominal Radiology, was 
held in Orlando, Florida, 
April 14-19. 
Robert McKinstry, MD, 
PhD, assistant professor of 
radiology, was appointed as 
a member of the National 
Institutes of Health Study 
Section, Center for Scientific 
Review, Special Emphasis 
Panel for Innovations in 
Pediatric Neuroimaging. He 
was appointed to the editor- 
ial board of the journal Neu- 
rology. McKinstry recently 
completed a one-year term 
as chair of the Steering 
Committee for a multicenter 
study, "The MRI study of 
normal brain development." 
Eduardo Moros, PhD, 
associate professor of radia- 
tion oncology, was elected to 
a one-year term as vice 





Robert Malyapa, MD, PhD, 
radiation oncology chief resi- 
dent, received an American 
Brachytherapy Society 
(ABS) Travel Award to 
attend the ABS 2002 Annual 




Samuel Achilefu, PhD, 
associate professor of 
radiology, as guest speaker, 
presented "The role of 
exogenous contrast agents in 
optical imaging of tumors 
and organ function 
monitoring" at the The 
Speed School of Engineering 
Seminar Series, University 






Jeffrey Bradley, MD, 
assistant professor of radia- 
tion oncology, spoke on 
"Image-guided radiotherapy 
utilizing PET fusion in lung 
carcinoma: a window toward 
the future" at the State 
University of New York, 
Stony Brook, June 5. 
Jeffrey Brown, MD, associ- 
ate professor of radiology, 
presented "Abdominal MRA" 
at the Tenth Scientific 
Meeting and Exhibition of 
the International Society for 
Magnetic Resonance in 
Medicine, Honolulu, Hawaii, 
May 18-24. 
Mickey Clarke, CNMT, 
division administration, Divi- 
sion of Nuclear Medicine, 
presented "Current status of 
nuclear medicine technology 
in the United States," at the 
22nd Annual Meeting of the 
Japanese Society of Nuclear 
Medicine Technology, 
Osaka, Japan, July 27 and 28. 
Carmen Dence, MS, 
research scientist of 
radiology, presented "[C-ll] 
tracers to quantify myocar- 
dial metabolism with PET" at 
the University of Cambridge, 
Wolfson Brain Imaging 
Center, Cambridge, England, 
May 30. 
Colin Derdeyn, MD, asso- 
ciate professor of radiology, 
spoke on "The carotid 
occlusion surgery study" and 
"Carotid angioplasty and 
stenting" at the Missouri 
Society of Radiologic 
Technologists Annual 
Meeting, Lake of the Ozarks, 
Missouri, April 18. He pre- 
sented the plenary lecture 
"Acute stroke intervention" 
at the American Society of 
Neuroradiology Annual 
Meeting, Vancouver, Canada, 
May 14. 
(Left to right) Doctors 
Charles Hechtman; 
Anurag Singh; Gregg 
Franklin; Jon Anders; 
Fengming Kong; Jeff 
Michalski, director, 
Clinical Division; Ana Botero, radiation oncology chief resident; Jeffrey Bradley, 
director, Radiation Oncology Residency Program; Robert Malyapa, radiation oncology 
assistant chief resident; Wayne Lamoreaux. 
i 
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Louis Gilula, MD, 
professor of radiology and 
of surgery, presented 
"Analysis of complex carpal 
trauma" at the San Francisco 
Bay Area Hand Society 
meeting, San Francisco, 
California, May 10. 
Perry Grigsby, MD, profes- 
sor of radiation oncology 
and of radiology, presented 
"Neoadjuvant chemotherapy 
and surgery versus standard 
radiotherapy for locally 
advanced cervix cancer. A 
meta-analysis using individ- 
lal patient data from 
•andomized controlled trials 
(RCTs)" at the 2nd 
iternational Conference on 
Cervical Cancer, M. D. 
Anderson Cancer Center, 
University of Texas, 
Houston, April 11-14. He 
spoke on "Place of 
chemotherapy in locally 
advanced bulky cervical 
:enters," "Place of radiother- 
apy in surgically staged 
endometrial cancers," "Place 
of radiotherapy in ovarian 
cancers" at the 8th Annual 
Meeting of Turkish 
Gynecologic Oncology 
Society, Antalya, Turkey, 
May 1-5. 
William Harms, BS, 
instructor in radiation oncol- 
ogy, spoke on "Technical 
requirements for participat- 
ing in advanced technology 
radiation oncology clinical 
trials" at the Radiation 




Jay Heiken, MD, professor 
of radiology, chief of abdom- 
inal imaging, and codirector 
of body computed tomogra- 
phy, spoke on "CT evalua- 
tion of pancreatic arcinoma" 
at the Abdominal Radiology 
Course 2002, sponsored 
by the society of Gastroin- 
testinal Radiologists and the 
European Society of Gas- 
trointestinal and Abdominal 
Radiology, Orlando, Florida, 
April 14-19. As visiting 
professor, he presented "CT 
colonography: technique, 
results, issues;" "Multi-slice 
CT: principles and applica- 
tions in the abdomen;" and 
"Characterization of hepatic 
masses with CT and MRI" at 
the University of Ottawa, 
Canada, May 30-31. Heiken 
presented "New concepts for 
optimizing contrast medium 
delivery"at the 4th 
International Symposium on 
Multidetector-Row CT, 
sponsored by Stanford 
University, San Francisco, 
California, June 20-23. 
Robert Malyapa, MD, PhD, 
radiation oncology chief 
resident, presented 
"Improved brachytherapy 
treatment planning using 
positron emission tomogra- 
phy (PET) for cervical 
cancer" at the 23rd 
American Brachytherapy 
Society Meeting, Orlando, 
Florida, May 22-24. 
Elizabeth McFarland, MD, 
associate professor of radiol- 
ogy, presented "Patient 
appraisals of CT colonogra- 
phy, conventional 
colonoscopy, and the bowel 
preparation" and served as 
moderator for "Diagnostic 
performance of CT colonog- 
raphy" at the Third Interna- 
tional Symposium of Virtual 
Colonoscopy, Boston, 
Massachusetts, April 8-10. 
She spoke on "CTA: pre and 
post operative evaluation of 
endovascular stent grafts;" 
CT colonography;" and 
"Evolving 3D CT body appli- 
cations" at the Oklahoma 
State Radiological Society 
Meeting, Tulsa, April 19 and 
20. McFarland presented 
"Prospective study of CT 
colonography (air vs. C02 
insufflation techniques) and 
colonoscopy: assessments of 
procedure times and image 
quality" at the Society of 
Gastrointestinal Radiology 
meeting, Orlando, Florida, 
April 14. 
Robert McKinstry, MD, 
PhD, assistant professor of 
radiology, spoke on "Diffu- 
sion tensor MR imaging in 
neuroradiology" at 
Radiology Grand Rounds, 
Medical College of Georgia, 
Augusta, April 19, and 
Radiology Grand Rounds, 
Northwestern University 
Medical center, Chicago, 
Illinois, June 12. He spoke on 
"MR imaging of normal brain 
maturation" at the Radiology 
Department, Tripler Army 
Medical Center, Honolulu, 
Hawaii, May 21. He pre- 
sented "Introduction to diffu- 
sion imaging," "Diffusion 
imaging and stroke evolu- 
tion," "Diffusion imaging pit- 
falls," and "Cranial nerves" at 
World Class MR and CT: 
Achieving Excellence in 
Neuro/Skeletal Imaging Con- 
ference, Minneapolis, Min- 
nesota, July 7. 
Jeff Michalski, MD, associ- 
ate professor of radiation 
oncology and director of the 
Clinical Division, presented 
"Medical updates in oncol- 
ogy practice: prostate can- 
cer: research & practice 
update" at the First Annual 
Siteman Oncology Nursing 
Symposium 2002, St. Louis, 
Missouri, April 5. He pre- 
sented "Conformal RT: the 
USA view; U.S. clinical trials 
of 3D CRT for prostate can- 
cer" at the MRC RT01 
Participants Meeting, 
London, England, April 26. 
Michalski spoke on "Clinical 
trials on 3D conformal radia- 
tion therapy" at the Quebec 
Association of Radiation 
Oncologists meeting, Trois- 
Rivieres, Canada, June 9. 
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Tom Miller, MD, PhD, 
professor of radiology and 
of biomedical engineering, 
spoke on "PET in cervical 
cancer and prostate cancer" 
at the 5th International 
Congress of Nuclear 
Oncology, Kusadasi, Turkey, 
May 1-3. 
Eduardo Moros, PhD, 
associate professor of radia- 
tion oncology, presented 
"Thermoradiotherapy engi- 
neering research, develop- 
ment and support" to the 
Department of Mechanical 
Engineering, University of 
Maryland, Baltimore, May 3. 
Nobuyuki Oyama, MD, 
PhD, visiting assistant pro- 
fessor in radiology, pre- 
sented "Diagnosis of 
recurrent prostate cancer 
using HC-acetate PET" at 
the 90th Annual Meeting of 
the Japanese Urological 
Association, Tokyo, Japan, 
April 19. He spoke on 
"Carbon-11-acetate PET 
imaging of recurrent 
prostate cancer" at the 97th 
Annual Meeting of the 
American Urological 
Association, Orlando, 
Florida, May 26. 
Carlos Perez, MD, profes- 
sor of radiation oncology 
and chair of the Department 
of Radiation Oncology, 
spoke on "Prostate cancer: 
state of the art" at the 2nd 
International Prostate 
Cancer Congress, 
St. Thomas, U.S. Virgin 
Islands, July 17. He pre- 
sented "Breast conserving 
therapy in Tl and T2 tumors" 
and "Radiation therapy in 
locally advanced breast 
cancer" at the First 
Interamerican Breast Cancer 
Conference, Cancun, 
Mexico, July 27. Perez pre- 
sented "Radiation for 
prostate cancer: state of the 
art" and "Hormone and radi- 
ation therapy in localizes 
prostate cancer" at the 
AstraZeneca Regional 
Urology Advisory Board, 
Mackinac Island, Michigan, 
August 1 and 2. 
David Piwnica-Worms, 
MD, PhD, professor of radi- 
ology and of molecular biol- 
ogy and pharmacology and 
director of the Molecular 
Imaging Center, presented 
"Strategies and development 
of radiopharmaceuticals for 
assessment of MDR and gene 
therapy" at the 7th Annual 
Oncology Conference: 
Targeted Diagnostics and 
Therapy and the 2nd Annual 
Scientific Session: Cancer- 
Specific Radiopharmaceuti- 
cals, St. Louis, Missouri, 
April 19-21. 
Joseph Roti Roti, PhD, 
professor of radiology and 
chief of the Division of 
Radiation and Cancer 
Biology, presented "The 
effect of chronic exposure to 
835.62 MHz FMCW or 847.74 
CMDA on the incidence of 
spontaneous tumors in rats" 
at the 24th Annual Meeting 
of the Bioelectromagnetics 
Society, Quebec City, 
Canada, June 23-27. 
Stuart Sagel, MD, profes- 
sor of radiology, chief of 
chest radiology, and codirec- 
tor of body computed 
tomography, presented "CT 
of the thoracic aorta" and 
"Unknown cases" at the 
Annual Conference on Chest 
Disease of the Fleischner 
Society, Brugge, Belgium, 
May 12-16. 
Maria Schmidt, MD, assis- 
tant professor of radiology, 
spoke on "Breast imaging 
and management guidelines" 
at Cancer of the Breast: 
Current Trends and Future 
Progress, St. Louis, Missouri, 
May 11. 
Joshua Shimony, MD, 
PhD, instructor in radiology, 
spoke on "Automated fuzzy 
clustering of neuronal path- 
ways in diffusion tensor 
tracking" at the Tenth Scien- 
tific Meeting and Exhibition 
of the International Society 
for Magnetic Resonance in 
Medicine, Honolulu, Hawaii, 
May 18-24. 
Barry Siegel, MD, profes- 
sor of radiology and of medi- 
cine and director of the 
Division of Nuclear 
Medicine, presented 
"Applications of FDG-PET in 
oncology" at the 7th Annual 
Oncology Conference: 
Targeted Diagnostics and 
Therapy and the 2nd Annual 
Scientific Session: Cancer- 
Specific Radiopharmaceuti- 
cals, St. Louis, Missouri, 
April 19-21. He presented 
"PET scanning of cancer: 
current indications" and 
served on discussion panels 
for Thoracic Tumors, and 
ENT Tumors at The 2002 
San Francisco Conference: 
Radiation Oncology, San 
Francisco, California, April 
19-21. He presented "PET: 
patient preparation, interpre- 
tation pitfalls and reimburse- 
ment issues" and "PET in 
oncology II" and served on 
the PET Case Review and 
Expert Panel at the 26th 
Annual Course of Clinical 
Nuclear Medicine, Cam- 
bridge, Massachusetts, 
April 29-May 2. Siegel spoke 
on "PET oncology 
overview," "PET evaluation 
of esophageal carcinoma," 
"PET oncology beyond 
FDG," and "PET in gyneco- 
logic neoplasms" at P.E.T. & 
Nuclear Cardiology in 
Dublin, Ireland, July 21-26. 
MALL1NCKRODT INSTITUTE OF RADIOLOi 
Marilyn Siegel, MD, pro- 
fessor of radiology and of 
pediatrics, spoke on "Fast 
MRI of small cell tumors in 
children: an NCI protocol" at 
the Children's Oncology 
Group Meeting, Jacksonville, 
lorida, April 16, and at the 
Society of Pediatric 
Radiology, Philadelphia, 
Pennsylvania, April 30. As 
visiting professor, she pre- 
sented "CT/MR of the liver: 
techniques and indications;" 
"CT/MR of retroperitoneal 
neoplasms: diagnosis and 
staging;" "Hemorrhagic/ 
ischemic brain injury in 
infants;" "Ultrasonography of 
neonatal renal diseases;" 
"MDCT of the airway;" and 
"Thymic CT in Children" at 
Kwong Wah Hospital, Hong 
Kong, June 17-21. Siegel 
spoke on "Sonography and 
CT of acute abdominal pain 
in children" at the Hong 
Kong Radiological Society, 
Hong Kong, June 17. 
Michael Welch, PhD, pro- 
fessor of radiology and of 
chemistry and codirector of 
the Division of Radiological 
Sciences, presented "Design 
and use of PET radiophar- 
maceuticals (other than 
FDG) for cancer diagnosis 
and therapy" at the 7th 
Annual Oncology Confer- 
ence: Targeted Diagnostics 
and Therapy and the 2nd 
Annual Scientific Session: 
Cancer-Specific Radiophar- 
maceuticals, St. Louis, Mis- 
souri, April 19-21. As invited 
speaker, he presented "New 
radioisotopes for PET" and 
"Myocardial metabolic imag- 
ing using l-[ll-C]-D-glucose, 
l-[ll-C]-palmitate and 1-[11- 
C]-acetate" at the Turku PET 
Symposium, Turku, Finland, 
May 25-28. 
Dmitriy Yablonskiy, PhD, 
assistant professor of radiol- 
ogy, presented "What 3He 
diffusion can tell about lung 
microstructure," "On the role 
of blood flow in brain tem- 
perature regulation," and 
"Microstructure of human 
lung as revealed by hyperpo- 
larized 3He diffusion MRI" at 
the Tenth Scientific Meeting 
and Exhibition of the 
International Society for 
Magnetic Resonance in 
Medicine, Honolulu, Hawaii, 
May 18-24. 
SYMPOSIA  
In this section ofFYI, only 
those faculty and staff 
who have Department of 
Radiology or Department 
of Radiation Oncology 






Annual Scientific Meeting 
Reno, Nevada 
Apri\ 20-24, 2002 
Eduardo Moros, PhD, 
cochair, Non-Invasive 
Treatment Monitoring and 
Treatment Planning. 
Joseph Roti Roti, PhD, 
chair, NAHS Hyperthermia 
and Radiation Sensitivity; 
cochair, NAHS Defining 
Thermal Goals for 
Hyperthermia. 
POSTER SESSIONS 
Robert VanderWaal, PhD; 
Beth Pierburg; Joseph 
Roti Roti, PhD, "Redox 
sensitive protein(s) are 
involved with anchoring 
DNA to the nuclear matrix." 
Mai Xu, MD, PhD; Robert 
Myerson, MD, PhD; 
Eduardo Moros, PhD; 
Clayton Hunt, PhD; 
William Straube, MS; 
Joseph Roti Roti, PhD, 
"DNA-dependent protein 
jinase regulates Werner 
syndrome protein linking 
aging to DNA repair." 
SCIENTIFIC SYMPOSIA 
Clayton Hunt, PhD, 
"HSP70 is not required for 
normal mouse development, 
viability, or fertility." 
Eduardo Moros, PhD; Petr 
Novak, MSc; William 
Straube, MS; Robert 
Myerson, MD, PhD, "The 
making of a clinical 
SURLAS: finalizing the scan- 
ning reflector mechanism." 
Eduardo Moros, PhD; Mai 
Xu, MD, PhD; William 
Straube, MS; Joseph Roti 
Roti, PhD, "Dynamics of 
cell culture media tempera- 
ture inside flasks kept in 
laboratory incubators." 
Robert Myerson, MD, 
PhD; Heather Bigott; 
John Engelbach; Jason 
Lewis, PhD; Deborah 
McCarthy, PhD; Terry 
Sharp; Joonyoung Kim, 
PhD; Michael Welch, PhD, 
"Monitoring the effect of 
mild hyperthermia on 
tumor hypoxia by Cu-ATSM 
PET scanning: preliminary 
studies." 
Petr Novak, MSc, "A novel 




William Straube, MS; 
Eduardo Moros, PhD, 
"In vitro measurement and 
analysis of backscattered 
ultrasound and its change 
with temperature." 
William Straube, MS; 
Eduardo Moros, PhD, 
"Noninvasive temperature 
estimation based on energy 
of backscattered ultra- 
sound." 
FOCAL SPOT, SUMMER 2002 29 
FYI 
SYMPOSIA 
Continued from page 29 
AMERICAN ROENTGEN 
RAY SOCIETY 
102nd Annual Meeting 
Atlanta, Georgia 
April 28-May 3, 2002 
RESIDENT TUTORIAL 
Marilyn Siegel, MD, "CT 
and US of the acute pediatric 
abdomen." 
CATEGORICAL COURSE - 
BODY CT 
Dennis Balfe, MD, "CT of 
the biliary tree." 
Jay Heiken, MD, "CT of 
small bowel obstruction." 
Marilyn Siegel, MD, 




Marilyn Siegel, MD, 
"Imaging of the acute pedi- 
atric abdomen." 
Pediatrics: CT and MRI — 
Imaging of the Pediatric 
Mediastinum 
Sanjeev Bhalla, MD, 
"Nonvascular lesions." 
Fernando Gutierrez, MD, 
"Vascular lesions." 
Pediatric Genitourinary Tract 
Marilyn Siegel, MD, 
"Renal masses." 
Ultrasound 
William Middleton, MD, 
"US evaluation of portal 
hypertension." 
Sharlene Teefey, MD, 
"US evaluation of TIPS." 
New Issues Forum 
William Middleton, MD, 
"Sonography of the shoulder." 
Sharlene Teefey, MD, 
"Sonography of the wrist." 
SCIENTIFIC EXHIBITS 
John Leyendecker, MD; 
Elizabeth McFarland, MD; 
Dennis Balfe, MD, 
"Colorectal polyp screening 
techniques: current status 
and panel discussion of bar- 
ium enema, colonoscopy, 




TARGETRY AND TARGET 
CHEMISTRY 
Turku, Finland 
May 23-25, 2002 
SCIENTIFIC SESSIONS 
Reports from the Laboratories 
Carmen Dence, MS; 
William Margenau; 
Christopher Bognar; 
Stephen Moerlein, PhD; 
Mohammed Al-Qahtani, 
PhD; Michael Welch, PhD, 
"GE PETtrace MEI 
MICROLAB: six years' 
experience with system." 
Gregory Gaehle; Sally 
Schwarz, MS, RPh; 
Michael Mueller; Michael 
Welch, PhD, "The installa- 
tion of a multi-radiopharma- 
ceutical PET facility at 
Washington University in 
St. Louis, MO, USA." 
Deborah McCarthy, PhD; 
Heather Bigott; Douglas 
Rowland, PhD; Todd 
Perkins; Thomas Voller; 
Richard Laforest, PhD; 
David Reichert, PhD; 
Michael Welch, PhD, 
"A research resource in 
radionuclide research." 
Other topics: Radiochemistry 
and Automation 
Douglas Rowland, PhD; 
Richard Laforest, PhD; 
Michael Welch, PhD, "The 
present status of a high 
current inclined target and 
solid target changer at 
Washington University." 
Sally Schwarz, MS, RPh; 
Keith Lechner; Michael 
Mueller; Gregory Gaehle; 
Michael Welch, PhD, 
"Radiopharmaceutical pro- 
duction quality control 
considerations." 
Lucie Tang; David 
Reichert, PhD; Deborah 
McCarthy, PhD; Michael 
Welch, PhD, "Remote and 
automated solvent extrac- 
tion of gallium-66." 
SOCIETY OF NUCLEAR 
MEDICINE 
49th Annual Meeting 
Los Angeles, California 
June 15-19, 2002 
Tom Miller, MD, PhD, 
chair, Scientific Program. 
Sally Schwarz, MS, RPh, 
comoderator, Radiopharma- 
ceutical Chemistry Track— 
Radiopharmacy II: 
Radiopharmaceuticals. 
Michael Welch, PhD, vice 
chair, Radiopharmaceutical 







Jason Lewis, PhD, 
"Cyclotron-produced 




Yuan-Chuan Tai, PhD; 
Michael Welch, PhD, 
"Instruments and radiophai 
maceuticals needed for 
modern molecular imaging 
techniques." 
SCIENTIFIC SESSIONS 
Pilar Herrero, MS; Donna 
Cassady, RN; Zulfa 
Kisrieva-Ware, MD, PhD; 
Robert Gropler, MD, 
"Myocardial fatty acid oxid 
tion is increased in patient' 
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I 
Jason Lewis, PhD; Yun- 
I peng Ye, PhD; Joonyoung 
Kim, PhD; John Engel- 
Ibach; Richard Laforest, 
|PhD; Michael Welch, PhD, 
tratumoral administration 
ofCu-64-ATSMorCu-61- 
VTSM: therapeutic compari- 
son in GW39 tumors." 
en Ping Li, PhD; Jason 
ewis, PhD; Joonyoung 
Kim, PhD; Carolyn Ander- 
son, PhD, "New somato- 
statin analog for 
radiolabeling with metals 




Wi eng Ping Li, PhD; Jason 
Lewis, PhD; Carolyn 
Anderson, PhD, "64Cu- 
DOTA-CTTHWGFTLC, a 
I selective gelatinase inhibitor 
for tumor imaging." 
Tom Miller, MD, PhD; 
,   I Perry Grigsby, MD, 
, I "Improved prognostic value 
| I of FDG-PET in patients with 
i 1 cervical cancer using a sim- 
i I pie visual analysis of tumor 
characteristics." 
Nobuyuki Oyama, MD, 
PhD; Datta Ponde, PhD; 
Joonyoung Kim, PhD; 
• John Engelbach; Nicole 
Mercer; Lynne Jones; 
Terry Sharp; Michael 
Welch, PhD, "MicroPET 
imaging of prostate cancer 
using 18F-FLT: androgen 
dependent tumor model 
study." 
Jeongsoo Yoo, PhD; David 
Reichert, PhD; Joonyoung 
Kim, PhD; Carolyn 
Anderson, PhD; Michael 
Welch, PhD, "A lipophilic 
D03A-based cyclen complex 
of wCu: synthesis, biodistrib- 
ution study and microPET 
imaging." 
Xiankai Sun, PhD; 
Joonyoung Kim, PhD; 
Michael Welch, PhD; Car- 
olyn Anderson, PhD, 
"Potential bone-imaging 






Michael Welch, PhD, 
"Radiosynthesis of 18F-fluo- 
ropropylpyrazoletriphenol, a 
new ligand selective for the 
estrogen receptor." 
Joonyoung Kim, PhD; 
Robert Myerson, MD, 
PhD; Heather Bigott; Pilar 
Herrero, MS; Terry Sharp; 
Jason Lewis, PhD; Michael 
Welch, PhD, "Quantitative 
analysis of wCu-ATSM kinet- 
ics in an animal tumor 
model." 
Deborah McCarthy, PhD; 
Michael Welch, PhD, 
"Production of therapeutic 
MCu radionuclide, using a 
ultra-small cyclotron." 
Stephen Moerlein, PhD; 
Joel Perlmutter, MD; 
Joonyoung Earn, PhD; 
John Engelbach; Lynne 
Jones; Nicole Mercer; 
Richard Laforest, PhD; 
Michael Welch, PhD, 
"MicroPET imaging of neu- 
roreceptor binding in rodent 
brain: comparison with ex 
vivo measurements." 
Peter Wolohan, PhD; 
David Reichert, PhD, 
"Comfa and docking study of 
novel estrogen receptor 
subtype selective ligands." 
AMERICAN ASSOCIATION 
OF PHYSICISTS IN 
MEDICINE 
44th Annual Meeting 
Montreal, Canada 
July 14-18, 2002 
Joseph Deasy, PhD, 
cochair, Radiobiology 
Scientific Session. 
Eric Klein, MS, recipient of 
the 2002 AAPM-IPEM 
Medical Physicals Travel 
Grant; cochair, Treatment 
Techniques and Delivery 
Systems Scientific Session. 
Zuofeng Li, DSc, cochair, 
IMRT Delivery 2 Scientific 
Session. 
Daniel Low, PhD, cochair, 
IMRT Validation/Verification 
2 Scientific Session. 
Eduardo Moros, PhD, 
cochair, Therapy—Other 
Scientific Session. 
Sasa Mutic, MS, cochair, 
Improvements in Conven- 
tional Planning Scientific 
Session. 
Jason Sohn, PhD, cochair, 
Therapy Poster Session: 
Image-guided Therapy 
Imaging Techniques and 





Daniel Low, PhD, "Clinical 
issues for IMRT4: measure- 
ment and analysis tech- 
niques for IMRT;" 
"Measurement and analysis 
techniques for IMRT." 
Sasa Mutic, MS, "Imaging 
radiation oncology: use of 
CT and PET in radiation 
therapy;" "Use of CT and 
PET in radiation therapy." 
POSTER SESSIONS 
Joseph Deasy, PhD, 
"CERR: a computational 
environment for radiother- 
apy research." 
Joseph Deasy, PhD; 
Konstantin Zakaryan, 
PhD, "A prototype Monte 
Carlo-based IMRT treatment 
planning research system." 
Joseph Deasy, PhD; 
Daniel Low, PhD, "Dose 
volume projections." 
Joseph Deasy, PhD, "An 
efficient relaxation method 
for dose-volume constraints 
in IMRT." 
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Robert Drzymala, PhD; 
ZuofengLi, DSc; Eric 
Klein, MS, "In vivo diode 
dosimetry and backscatter." 
Eric Klein, MS, "Head 
scatter and surface/buildup 
dose characteristics for 6, 10, 
and 18 MV photons from am 
Elekta Precise accelerator." 
Fengming Kong, MD; Jose 
Garcia-Ramirez, MS; Eric 
Klein, MS, "A new treat- 
ment technique to irradiate 
internal mammary nodes in 
breast cancer." 
Daniel Low, PhD, "Gel 
dosimetry by MRI using 3D 
gradient echo sequences." 
Daniel Low, PhD; Sasa 
Mutic, MS; Tom Miller, 
MD, PhD; Jeffrey 
Williamson, PhD; Perry 
Grigsby, MD, "Can IMRT 
replace intracavitary 
brachytherapy?" 
Robert Malyapa, MD, PhD; 
Sasa Mutic, MS; Daniel 
Low, PhD; Imran Zoberi, 
MD; Walter Bosch, DSc; 
Tom Miller, MD, PhD; 
Perry Grigsby, MD, 
"FDG-PET guided dose 
optimization in HDR 
brachytherapy for treatment 
of cervical cancer." 
Sasa Mutic, MS; Robert 
Malyapa, MD, PhD; Perry 
Grigsby, MD; Imran 
Zoberi, MD; Daniel Low, 
PhD, "Treatment planning 
guidelines regarding the use 
of CT/PET-guided IMRT for 
carcinoma of the cervix with 
para-aortic lymph node 
involvement." 
Jason Sohn, PhD, "Com- 
parison of measurements 
with radiochromic films and 
Monte Carlo simulation for 
small beams in heteroge- 
neous phantoms." 
Jeffrey Williamson, PhD; 
Zuofeng Li, DSc, "Thermo- 
luminescent dosimetry of a 
new type of 1-125 seed, 
SourceTech Medical model 
STM1251." 
SCIENTIFIC SESSIONS 
Imad Ali, PhD; Corneliu 
Costescu, PhD; Milos 
Vicic, PhD; Jeffrey 
Williamson, PhD, "Depen- 
dence of radiochromic film 
optical density post-expo- 
sure darkening kinetics on 
dose and dose fractiona- 
tion." 
Corneliu Costescu, PhD; 
Jeffrey Williamson, PhD; 
Milos Vicic, PhD, "On the 
influence of the photon scat- 
tering model on Monte Carlo 
simulation of low energy 
photon brachytherapy dose 
distributions." 
Joseph Deasy, PhD, "Con- 
vexity and multiple local 
minima issues in IMRT 
treatment planning." 
Zuofeng Li, DSc; Eric 
Klein, MS; Robert 
Drzymala, PhD; James 
Purdy, PhD, "Photoneutron 
dose levels in a linear 
accelerator room with lead 
shielding." 
Daniel Low, PhD; Jeffrey 
Bradley, MD; David 
Politte, DSc; Sasa Mutic, 
MS; Joseph Deasy, PhD, 
"4D (time-dependent) 
measurements of breathing 
motion using multislice CT 
scanning." 
Robert Malyapa, MD, PhD; 
Sasa Mutic, MS; Perry 
Grigsby, MD; Walter 
Bosch, DSc; Imran Zoberi, 
MD; Farrokh Dehdashti, 
MD; Tom Miller, MD, PhD; 
Daniel Low, PhD, "PET- 
guided-IMRT treatment for 
cervical carcinoma with 
positive para-aortic lymph 
nodes—a dose escalation 
treatment planning study." 
Eduardo Moros, PhD; Petr 
Novak, MSc; William 
Straube, MS; Robert 
Myerson, MD, PhD, "Clini- 
cal design of a system for 
simultaneous ultrasound 
hyperthermia and electron 
beam therapy." 
Jason Sohn, PhD; Daniel 
Low, PhD, "Characteriza- 
tion of a commercial optical 
CT scanner for imaging 
BANG® Polymer Gel 
Dosimeters." 
Jason Sohn, PhD; Daniel 
Low, PhD; Robert 
Drzymala, PhD; Eric 
Klein, MS, "Inhomogeneity 
correction for small beams 
used during IMRT." 
William Straube, MS; 
Eduardo Moros, PhD, "The I 
effect of temperature change | 
on backscattered ultrasound 
power." 
Milos Vicic, PhD; Jeffrey 
Williamson, PhD; Joseph 
Deasy, PhD; Daniel Low, 
PhD, "Towards sub-minute 
Monte Carlo based 
dosimetry." 
Jefffrey Williamson, PhD; 
Sicong Li, DSc; Kyongtae 
Bae, MD, PhD; John 
Matthews, DSc; Perry 
Grigsby, MD; Kim Nguyen, 
"Dosimetric implications of 
soft-tissue deformation in 
intracavitary brachytherapy 
of cervical cancer." 
Konstantin Zakaryan, 
PhD; Joseph Deasy, PhD. 
"Wavelet compression of 
beamlet dose distributions 
for IMRT treatment plan- 
ning." mn 
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(Seated, left to right) Doctors Juliet Fallah; Cynthia Santillan; Thelnta 
Lopes; Christine Menias, assistant director, Diagnostic Radiology 
Residency Program; Lawrence Kotner, assistant director, Diagnostic 
Radiology Residency Program; Scott Andersen; James Goddard, 
diagnostic radiology chief resident; Gilbert Jost, director of the 
Institute; Sailendra Naidu, diagnostic radiology chief resident; Robert 
Kadner; Sanjeev Bhalla; Daniel Picus, chief, Division of Diagnostic 
Radiology; Bonnie Joe; Andrew Bierhals. (Second row) Doctors Paul 
Broadbent, David Mueller, Gregory Sanders, John Leyendecker, 
Tammie Benzinger, Vladislav Gorengaut, Markus Lammie, Noel Dias, 
Joseph Philip, Wrenn Wooten, Vikram Patel, Mark Bakalars, Avi 
Mazumdar, Franklin Marden, Yuming Yin, Feiyu Xue, Tito Rosas, 
Dallas Sorrell, Jason Wagner, Aamer Farooki, Huy Tran, Joseph 
Konstantarakis, Catherine Appleton, Christine Peterson, Karen Caudill, 
John Agles, Ambrose Huang, Anand Singh, Indunil Karunasekera, 
Matthew Wiggins, Amy Nordman, Gina Bowers. (Third row) Doctors 
Dana Sampalaneau, Srnivasa Prasad, Mehdi Poutschi-Amin, Ronan 
McDermott, Ronald Gerstle, Noah Appel, Francisco Rodriguez, 
Edward Lee, Michael Gelbart, Brett Gratz, Jason Oliphant, David 
Johnston, Jennifer Lee, Richard Heller, Kianoush Rezaei, Cary 
Shlimovitz, Peter Chuang. 
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